文献速递颅颌面外科美容整形创面修复

面部重建手术商业市场份额下降:对学术整形外科及未来人才培养的影响

Declining commercial market share in facial reconstructive surgery: Implications for academic plastic surgery and training future generations.
PubMed 文献 · J Plast Reconstr Aesthet Surg · 2022-08-27

该研究基于美国IBM MarketScan商业保险数据库2007至2016年数据,分析鼻整形、眼睑手术和皮肤癌重建中整形外科医生所占比例的变化趋势。共纳入430,472例手术,整形外科医生占比每年分别相对耳鼻喉科医生下降2.1%(鼻整形)、相对眼科医生下降2.0%(眼睑手术)、相对皮肤科医生下降3.0%(皮肤癌重建)(p<0.001)。作者结论为整形外科正在失去这些面部重建手术的商业市场份额,需制定策略以保护市场份额并避免影响学术中心和住院医师教育。

要点

  • 2007至2016年美国商业保险数据中,整形外科医生在鼻整形、眼睑手术和皮肤癌重建中的占比逐年下降。
  • 鼻整形相对耳鼻喉科医生年降2.1%,眼睑手术相对眼科医生年降2.0%,皮肤癌重建相对皮肤科医生年降3.0%(p<0.001)。
  • 当诊断或前序操作源自解剖学专科转诊基础时,整形外科医生实施手术的可能性更低。

核心结论

  • 整形外科医生正在失去历史上由本专业实施的面部重建手术的商业市场份额。
  • 作者认为整形外科必须制定策略以保护这些手术的商业市场份额,并避免对学术中心和住院医师教育造成损害。

研究设计与样本

  • 研究查询IBM® MarketScan® Research Databases,提取2007至2016年在美国接受商业保险覆盖的鼻整形、眼睑手术和皮肤癌重建的患者。
  • 研究识别手术医生专科,并使用泊松回归模型分析每种手术提供者专科的预测因素,调整患者性别、地区、机构设置和诊断。
  • 研究共纳入430,472例鼻整形、眼睑手术和皮肤癌重建手术。

主要发现

  • 整形外科医生实施的鼻整形比例每年相对耳鼻喉科医生下降2.1%(p<0.001)。
  • 整形外科医生实施的眼睑手术比例每年相对眼科医生下降2.0%(p<0.001)。
  • 整形外科医生实施的皮肤癌重建比例每年相对皮肤科医生下降3.0%(p<0.001)。
  • 若 underlying diagnosis 或前序操作源自「解剖学」专科的转诊基础,整形外科医生实施该手术的可能性更低:鼻窦疾病对耳鼻喉科(IRR 0.829)、眼睑或眼眶疾病对眼科(IRR 0.646)、Mohs切除对皮肤科(IRR 0.381)(p<0.001)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: As a surgical discipline without anatomic boundaries, plastic surgery overlaps with several other specialties. This study aims to measure longitudinal trends in the proportion of commercially reimbursed procedures performed by plastic surgeons compared to other specialists. We hypothesize that there is encroachment in commercial market share by anatomically defined subspecialists within otolaryngology, ophthalmology, and dermatology. METHODS: The IBM® MarketScan® Research Databases were queried to extract patients who underwent rhinoplasty, eyelid procedures, and skin cancer reconstruction covered by commercial insurance from 2007 to 2016 in the USA. Surgeon specialty was identified. Poisson regression modeled predictors of provider specialty for each procedure over time, adjusting for patient gender, region, facility setting, and diagnosis. RESULTS: A total of 430,472 rhinoplasty, eyelid, and skin cancer procedures were performed during the study period. For each year, the proportion of cases performed by plastic surgeons decreased by 2.1% for rhinoplasty compared to otolaryngologists, 2.0% for eyelid procedures compared to ophthalmologists, and 3.0% for skin cancer reconstruction compared to dermatologists (p<0.001). Plastic surgeons were less likely to perform the procedure if the underlying diagnosis or preceding procedure drew from referral bases of "anatomic" specialists, such as sinonasal disease for otolaryngologists (incidence rate ratio [IRR] 0.829), disorders of the eyelid or orbit for ophthalmologists (IRR 0.646), and Mohs excision for dermatologists (IRR 0.381) (p<0.001). CONCLUSIONS: Plastic surgeons are losing ground on commercially reimbursed facial reconstructive procedures historically performed by the specialty. Plastic surgeons must develop strategies to preserve the commercial market share of these procedures and avoid compromise to academic centers and resident education.

来源:J Plast Reconstr Aesthet Surg,查看原文。版权归原作者所有。

引用

  1. Rochlin DH, Matros E, Sheckter CC, et al. Declining commercial market share in facial reconstructive surgery: Implications for academic plastic surgery and training future generations. J Plast Reconstr Aesthet Surg. 2022. PMID: 36241505. doi:10.1016/j.bjps.2022.08.071

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。